These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 11092663

  • 1. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure.
    Nieminen MS, Akkila J, Hasenfuss G, Kleber FX, Lehtonen LA, Mitrovic V, Nyquist O, Remme WJ.
    J Am Coll Cardiol; 2000 Nov 15; 36(6):1903-12. PubMed ID: 11092663
    [Abstract] [Full Text] [Related]

  • 2. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators.
    Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, Hutchins S, Leier CV, LeJemtel TH, Loh E, Nicklas J, Ogilby D, Singh BN, Smith W.
    Circulation; 2000 Oct 31; 102(18):2222-7. PubMed ID: 11056096
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure.
    Kivikko M, Antila S, Eha J, Lehtonen L, Pentikäinen PJ.
    J Clin Pharmacol; 2002 Jan 31; 42(1):43-51. PubMed ID: 11808823
    [Abstract] [Full Text] [Related]

  • 4. Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.
    Bergh CH, Andersson B, Dahlström U, Forfang K, Kivikko M, Sarapohja T, Ullman B, Wikström G.
    Eur J Heart Fail; 2010 Apr 31; 12(4):404-10. PubMed ID: 20335355
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone.
    Nanas JN, Papazoglou PP, Terrovitis JV, Kanakakis J, Dalianis A, Tsolakis E, Tsagalou EP, Agrios N, Christodoulou K, Anastasiou-Nana MI.
    Am J Cardiol; 2004 Nov 15; 94(10):1329-32. PubMed ID: 15541261
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy and safety of intravenous levosimendan compared with dobutamine in decompensated heart failure].
    Wang L, Cui L, Wei JP, Li GP, Qi GX, Hao YM, Wang WZ, Li HM, Liu J, Jiang DJ, Zhang YD.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun 15; 38(6):527-30. PubMed ID: 21033135
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery.
    Labriola C, Siro-Brigiani M, Carrata F, Santangelo E, Amantea B.
    Int J Clin Pharmacol Ther; 2004 Apr 15; 42(4):204-11. PubMed ID: 15124978
    [Abstract] [Full Text] [Related]

  • 11. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F.
    Ital Heart J; 2003 May 15; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines.
    Delle Karth G, Buberl A, Geppert A, Neunteufl T, Huelsmann M, Kopp C, Nikfardjam M, Berger R, Heinz G.
    Acta Anaesthesiol Scand; 2003 Nov 15; 47(10):1251-6. PubMed ID: 14616323
    [Abstract] [Full Text] [Related]

  • 13. Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.
    Duman D, Palit F, Simsek E, Bilgehan K, Sacide A.
    Can J Cardiol; 2009 Oct 15; 25(10):e353-6. PubMed ID: 19812809
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sustained hemodynamic effects of intravenous levosimendan.
    Kivikko M, Lehtonen L, Colucci WS.
    Circulation; 2003 Jan 07; 107(1):81-6. PubMed ID: 12515747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.